BioSpace News Archive

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals for formulation development and clinical batch manufacture of drug capsules of Ropidoxuridine.

Alcami Corporation, a leading contract development and manufacturing organization, announced the appointment of Jamie Iudica to Chief Manufacturing Officer.

Molecular Templates, Inc. has received clearance by the United States Food and Drug Administration (“FDA”) following review of its Investigational New Drug Application (“IND”) to proceed for clinical testing of its novel MT-8421 ETB program targeting CTLA-4 in patients with relapsed/refractory solid tumors previously exposed to checkpoint inhibitors.

Bongiovi Medical & Health Technologies’ (BMHT) medical team, led by lead investigator Dr. Thomas Haffey and CTO Joseph Butera III, presented the findings of the groundbreaking study at The American College of Cardiology/World Heart Foundation annual meeting March 4-8 in New Orleans.

Stuart Therapeutics, Inc. today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.

SpectronRx, a comprehensive radiopharmaceutical contract development and manufacturing organization (rCDMO), announced today that initial construction of its Bunker Hill, Indiana, medical isotope production facility has been completed and two new cyclotrons have been installed.

CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, announced its FUTURES National Conference will be held from April 20-23, 2023 in San Diego, California.

The American Academy of Orthopaedic Surgeons presented its 2023 Humanitarian Award to Mark S. Myerson MD, FAAOS, of Denver, Colo.

The American Academy of Orthopaedic Surgeons presented its 2023 Diversity Award to Mary I. O’Connor, MD, FAOA, FAAHKS, FAAOS.

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces the appointment of Dr. John C. Bell and Dr. Pedro Romero as key scientific advisors.